Targeting IDH1 as a Pro-Senescent Therapy in High-Grade Serous Ovarian Cancer
Molecular Cancer Research - United States
doi 10.1158/1541-7786.mcr-18-1233
Full Text
Open PDFAbstract
Available in full text
Date
May 20, 2019
Authors
Publisher
American Association for Cancer Research (AACR)